Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck KGaA (OTC Pink - Current Information:MKGAY)

33.33
Delayed Data
As of May 27
 -0.04 / -0.12%
Today’s Change
26.91
Today|||52-Week Range
36.54
+2.87%
Year-to-Date
Cancer Immunotherapies Take Center Stage in Pre-ASCO Abstract Releases
May 26 / MotleyFool.com - Paid Partner Content
Merck KGaA (MKGAF) Q1 Earnings Increased Y/Y
May 19 / Zacks.com - Paid Partner Content
Merck KGaA's Q1 Earnings Increase Y/Y, Offers 2016 View
May 20 / Zacks.com - Paid Partner Content
Merck KGaA (MKGAF) Q1 Earnings: What Awaits the Stock?
May 16 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close33.37
Today’s open33.26
Day’s range33.21 - 33.35
Volume2,606
Average volume (3 months)9,941
Market cap$12.8B
Dividend yield1.20%
Data as of 2:14pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-19.61%
Earnings growth (this year)--
Earnings growth (next 5 years)+10.50%
Revenue growth (last year)-6.71%
P/E ratio--
Price/Sales3.01
Price/Book3.14

Competitors

No competitors data available.

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)$0.55
Annual revenue (last year)$14.2B
Annual profit (last year)$1.2B
Net profit margin8.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Stefan Oschmann
Chief Financial Officer
Marcus Kuhnert
Corporate headquarters
Darmstadt, Hessen

Forecasts

Partner Offers

Search for Jobs